ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 33 filers reported holding ONCOSEC MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | +50.0% | 12,954 | +136.6% | 0.00% | – |
| Q2 2022 | $4,000 | -60.0% | 5,476 | -36.8% | 0.00% | – |
| Q1 2022 | $10,000 | +100.0% | 8,658 | +62.1% | 0.00% | – |
| Q4 2021 | $5,000 | -58.3% | 5,340 | +27.8% | 0.00% | – |
| Q2 2021 | $12,000 | -20.0% | 4,178 | -6.0% | 0.00% | – |
| Q3 2020 | $15,000 | – | 4,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SALZHAUER MICHAEL | 277,312 | $591,000 | 0.24% |
| Avidity Partners Management LP | 2,945,000 | $6,273,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 316,229 | $674,000 | 0.12% |
| J. Goldman & Co LP | 790,242 | $1,683,000 | 0.08% |
| Sandbox Financial Partners, LLC | 25,000 | $53,000 | 0.04% |
| Virtu Financial LLC | 25,166 | $54,000 | 0.01% |
| D.A. DAVIDSON & CO. | 108,500 | $231,000 | 0.00% |
| J. Goldman & Co LP | 26,300 | $56,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 361,401 | $770,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 49,500 | $105,000 | 0.00% |